KANION
LIVE

Serial Number

78280590

Owner

JIANGSU KANION PHARMACEUTICAL CO., LTD.

Attorney

Prakash NAMA

First Use Date

Jan 25, 2000

Filing Date

Jul 29, 2003

Add to watchlist:

No watchlists yet
View on USPTO

KANION Trademark

Serial Number: 78280590 • Registration: 2928716

KANION is a trademark filed by JIANGSU KANION PHARMACEUTICAL CO., LTD. on July 29, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

JIANGSU KANION PHARMACEUTICAL CO., LTD. (7 trademarks)

LIANYUNGANG ECONOMIC & TECHNOLOGICAL DEV
JIANGSU , CN

Entity Type: 16

Trademark Details

Filing Date

July 29, 2003

Registration Date

March 1, 2005

First Use Anywhere

January 25, 2000

First Use in Commerce

August 12, 2000

Published for Opposition

December 7, 2004

Goods & Services

Medicines for the treatment of gynecological diseases, obstetric diseases, bleeding after induced abortion, abdominal pain after insertion of intrauterine contraceptive device, mammary diseases, diseases of the urogenital tract, spondylitis, osteoarthritis, arthritis, painful heel, osteoarthrosis deformans endemica, hemicrania, cluster headache, tensional headache, hyperlipemia, blood hyperviscosity, brain trauma syndrome, vertigo, atherosclerosis, premonitory apoplexy, ischemic apoplexy and its sequela, gastrointestinal disease, deficiency of kidney-yin, lumbago, painful legs, neurasthenia, cardiovascular diseases, cerebrovascular diseases, menopause syndrome, excessive blood lipid, irregular flow of Qi, hypochondriac pain, dysmenorrheal, influenza, inflammation of the upper respiratory tract, pharyngitis, pneumonia and epidemic parotitis, wind-cold headache, pain in the supra-orbital bone, distention and pain due to nasal sinusitis, wind-damp headache and nervous headache; Chinese medicines for the treatment of gynecological diseases, obstetric diseases, bleeding after induced abortion, abdominal pain after insertion of intrauterine contraceptive device, mammary diseases, diseases of the urogenital tract, spondylitis, osteoarthritis, arthritis, painful heel, osteoarthrosis deformans endemica, hemicrania, cluster headache, tensional headache, hyperlipemia, blood hyperviscosity, brain trauma syndrome, vertigo, atherosclerosis, premonitory apoplexy, ischemic apoplexy and its sequela, gastrointestinal disease, deficiency of kidney-yin, lumbago, painful legs, neurasthenia, cardiovascular diseases, cerebrovascular diseases, menopause syndrome, excessive blood lipid, irregular flow of Qi, hypochondriac pain, dysmenorrheal, influenza, inflammation of the upper respiratory tract, pharyngitis, pneumonia and epidemic parotitis, wind-cold headache, pain in the supra-orbital bone, distention and pain due to nasal sinusitis, wind-damp headache and nervous headache; nutritional supplements; baby food; medicinal preparations in liquid form for dissolving cholesterol, medicinal preparations in liquid form for softening and expanding blood vessels, medicinal preparations in liquid form for removing blood lipid, medicinal preparations in liquid form for the treatment of hypertension, hyperlipemia, senile dementia, coronary heart disease, atherosclerosis, hyperlipemia; ginseng for medicinal use; medicinal tea for weight-loss; herbal teas for medicinal purposes; dietary supplement tablets for the use of anti-fatigue, protecting the liver against chemical lesion, improving the blood circulation, smoothing the skin, refreshing the mind, invigorating vital energy, promoting metabolism, improving immunity and regulating bilaterally the functional balance of human body; food supplements; nutritional supplements; nutritionally fortified beverages; and surgical dressings

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 10, 2024 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Aug 10, 2024 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 10, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 30, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
May 9, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 1, 2024 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2018 TCCA
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 9, 2014 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 9, 2014 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 9, 2014 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 9, 2014 APRE
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Apr 28, 2014 89AF
TEAS SECTION 8 & 9 RECEIVED
Apr 28, 2014 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2014 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Oct 22, 2010 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 18, 2010 APRE
TEAS SECTION 8 RECEIVED
Oct 14, 2010 ES8R
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2010 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2010 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 2, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 2, 2008 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 1, 2005 R.PR
PUBLISHED FOR OPPOSITION
Dec 7, 2004 PUBO
NOTICE OF PUBLICATION
Nov 17, 2004 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 30, 2004 PREV
ASSIGNED TO LIE
Sep 13, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2004 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2004 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2004 TROA
NON-FINAL ACTION MAILED
Feb 12, 2004 CNRT
ASSIGNED TO EXAMINER
Feb 9, 2004 DOCK